DEA schedule
Is Anoro Ellipta a controlled substance?
Anoro Ellipta contains umeclidinium bromide and vilanterol trifenatate. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Anoro Ellipta (umeclidinium bromide and vilanterol trifenatate) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and umeclidinium bromide and vilanterol trifenatate is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Anoro Ellipta?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 1 prescription listings from 1 labelers, none with a DEA schedule |
| DEA controlled substances list | umeclidinium bromide and vilanterol trifenatate is not on the list |
Anoro Ellipta NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0173-0869 | Anoro Ellipta | powder | 62.5 ug/1; 25 ug/1 | GlaxoSmithKline LLC | None |
Questions
Is Anoro Ellipta a controlled substance?
No. Anoro Ellipta (umeclidinium bromide and vilanterol trifenatate) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and umeclidinium bromide and vilanterol trifenatate is not on the DEA controlled substances list.
Is Anoro Ellipta a narcotic?
No. Anoro Ellipta (umeclidinium bromide and vilanterol trifenatate) is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Anticholinergic and beta2-Adrenergic Agonist.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.